1.
Chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma: The evolving Canadian landscape. Can Hematol Today [Internet]. 2023 Nov. 6 [cited 2026 Aug. 22];2(3):27-31. Available from: https://canadianhematologytoday.com/article/view/2-3-bhella